Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2017 August;58(4) > The Journal of Cardiovascular Surgery 2017 August;58(4):508-17

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEW  RECENT DEVELOPMENTS IN THE MANAGEMENT OF IN-STENT RESTENOSISFREEfree


The Journal of Cardiovascular Surgery 2017 August;58(4):508-17

DOI: 10.23736/S0021-9509.17.09953-0

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

In-stent restenosis management: the best is yet to come

Jos C., van den BERG 1, 2

1 Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie, Inselspital, Bern, Switzerland; 2 Centro Vascolare Ticino, Ospedale Regionale di Lugano, Lugano, Switzerland


FULL TEXT  


The use of drug-eluting stents and of drug-coated balloons have mitigated the prevalence of in-stent restenosis, however in-stent remains a problem that continues to affect the long-term outcomes of femoro-popliteal endovascular therapy. This paper will provide an overview on the latest data with regard to the treatment of femoro-popliteal in-stent restenosis.


KEY WORDS: Femoral artery - Vascular graft occlusion - Drug-eluting stents - Balloon angioplasty

top of page

Publication History

Issue published online: June 5, 2017
Article first published online: March 20, 2017

Cite this article as

van den Berg JC. In-stent restenosis management: the best is yet to come. J Cardiovasc Surg 2017;58:508-17. DOI: 10.23736/S0021-9509.17.09953-0

Corresponding author e-mail

jos.vandenberg@eoc.ch